Stem Cell Therapy Announces That Merger Is Progressing on Schedule (Marketwire)
TAMPA, FL–(Marketwire – December 23, 2009) – Stem Cell Therapy International, Inc. ( OTCBB : SCII ) announced that its pre-closing conditions for its merger with Histostem Co. Ltd. (“Histostem”) are proceeding on schedule with an expected close of the merger in January 2010. Shareholders have approved changing the Company’s name to AmStem Corporation and approved an increase in authorized …
(more business here…)
